Jennifer Arney

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease”.

Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease

American Journal of Nephrology(2023)10.1159/000530988

N/A

0DataRank · unranked

10 citations

Peter Richardson, Michael A. Herrera, Julia M. Akeroyd, Shehrezade A. Jafry, Glenn T. Gobbel +7 more

Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study

Cardiorenal Medicine(2023)10.1159/000535829

N/A

0DataRank · unranked

3 citations

L. Parker Gregg, Sheena Wydermyer, Michael A. Herrera, Peter Richardson, Michael E. Matheny +6 more